Transcatheter Intervention for Congenital Defects Involving the Great Vessels: JACC Review Topic of the Week

J Am Coll Cardiol. 2021 Jan 5;77(1):80-96. doi: 10.1016/j.jacc.2020.11.019.

Abstract

Since the development of balloon angioplasty and balloon-expandable endovascular stent technology in the 1970s and 1980s, percutaneous transcatheter intervention has emerged as a mainstay of therapy for congenital heart disease (CHD) lesions throughout the systemic and pulmonary vascular beds. Congenital lesions of the great vessels, including the aorta, pulmonary arteries, and patent ductus arteriosus, are each amenable to transcatheter intervention throughout the lifespan, from neonate to adult. In many cases, on-label devices now exist to facilitate these therapies. In this review, we seek to describe the contemporary approach to and outcomes from transcatheter management of major CHD lesions of the great vessels, with a focus on coarctation of the aorta, single- or multiple-branch pulmonary artery stenoses, and persistent patent ductus arteriosus. We further comment on the future of transcatheter therapies for these CHD lesions.

Keywords: coarctation of the aorta; congenital heart disease; interventional cardiology; patent ductus arteriosus; pulmonary artery stenosis.

Publication types

  • Review

MeSH terms

  • Angiography
  • Angioplasty, Balloon*
  • Aortic Coarctation / diagnostic imaging
  • Aortic Coarctation / therapy*
  • Aortography
  • Ductus Arteriosus, Patent / diagnostic imaging
  • Ductus Arteriosus, Patent / therapy*
  • Humans
  • Stenosis, Pulmonary Artery / congenital
  • Stenosis, Pulmonary Artery / diagnostic imaging
  • Stenosis, Pulmonary Artery / therapy*
  • Stents*